The "Start-Stop" Reality: New Data Reveals Complex Patterns in GLP-1 Adherence for Type 2 Diabetes
CHICAGO — The landscape of type 2 diabetes management has been irrevocably altered by the rise of glucagon-like peptide-1 (GLP-1) receptor agonists. Drugs like liraglutide, semaglutide, and tirzepatide have become cornerstones of modern metabolic…
The New Reality: Why Millions are "Retiring from Retirement" and the Hidden Financial Traps
In an era defined by longer life expectancies and a shifting economic landscape, the traditional model of a "clean break" retirement is rapidly vanishing. More Americans than ever are choosing to "retire from retirement," re-entering…